Cited by 45Cellular transport and secretionCaveolin-1 and cellular processesReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 94 of the 98 references it cites were found in a registry or an index; 71 of the 174 sources its claims cite were checked for support.

Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice

Open access
Tao, Wensi, Moore, Robert, Smith, Elizabeth R., Xu, Xiang-Xi·2016·Frontiers in Cell and Developmental Biology

Abstract

Disabled-2 (Dab2) is a clathrin and cargo binding endocytic adaptor protein, and cell biology studies revealed that Dab2 plays a role in cellular trafficking of a number of transmembrane receptors and signaling proteins. A PTB/PID domain located in the N-terminus of Dab2 binds the NPXY motif(s) present at the cytoplasmic tails of certain transmembrane proteins/receptors. The membrane receptors reported to bind directly to Dab2 include LDL receptor and its family members LRP1 and LRP2 (megalin), growth factor receptors EGFR and FGFR, and the cell adhesion receptor beta1 integrin. Dab2 also serves as an adaptor in signaling pathways. Particularly, Dab2 facilitates the endocytosis of the Ras activating Grb2/Sos1 signaling complex, controls its disassembly, and thereby regulates the Ras/MAPK signaling pathway. Cellular analyses have suggested several diverse functions for the widely expressed proteins, and Dab2 is also considered a tumor suppressor, as loss or reduced expression is found in several cancer types. Dab2 null mutant mice were generated and investigated to determine if the findings from cellular studies might be important and relevant in intact animals. Dab2 conditional knockout mice mediated through a Sox2-Cre transgene have no obvious developmental defects and have a normal life span despite that the Dab2 protein is essentially absent in the mutant mice. The conditional knockout mice were grossly normal, though more recent investigation of the Dab2-deficient mice revealed several phenotypes, which can be accounted for by several previously suggested mechanisms. The studies of mutant mice established that Dab2 plays multiple physiological roles through its endocytic functions and modulation of signal pathways.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review synthesizes cell-culture and mouse-knockout evidence that Disabled-2 (Dab2), a clathrin/cargo-binding endocytic adaptor, has multiple physiological roles despite Dab2-null mice being largely normal. Phenotypes in cholesterol homeostasis, kidney protein reuptake, mammary involution, tumor risk, and diet-induced adipose expansion are attributed mainly to Dab2’s endocytic functions and modulation of Ras/MAPK signaling.

Key findings

  • Dab2 conditional knockout mice generated with Sox2-Cre have no obvious developmental defects and a normal life span, with Dab2 protein essentially absent; unchallenged mice are grossly normal.
  • Reported phenotypes include mild proteinuria, increased serum cholesterol, delayed mammary involution, resistance to high-fat/high-calorie diet-induced weight gain in juvenile mice, and increased tumor incidence in aged mice at about 10%, mainly in uterus, ovary, liver, mammary gland, and colon.
  • In LDL receptor endocytosis, Dab2 loss alone causes only a small increase in serum cholesterol, but in the absence of Arh, additional Dab2 loss greatly augments serum LDL and cholesterol to levels similar to LDL receptor null mice; Dab2 is expressed in liver sinusoidal endothelial cells, not hepatocytes.
  • Loss of Dab2 expression occurs in about 90% of ovarian cancers and is an early event; Dab2 is proposed as a tumor suppressor, with tumor suppressor functions attributed to suppressing Ras/MAPK signaling, epithelial organization, and cell adhesion/migration.

Methods

  • Narrative review integrating published cell-culture studies, genetic mouse models (including constitutive and conditional knockouts such as Sox2-Cre and aP2-Cre), and prior phenotypic characterizations.
  • Expression profiling uses public GeneAtlas microarray datasets for mouse and human tissues, with Dab2 mRNA ranked by abundance and averaged across probe sets.
  • Main analysis is qualitative synthesis of Dab2 mutant phenotypes (summarized in Table 1) and proposed mechanisms, especially endocytosis and Ras/MAPK regulation; no new primary experimental cohort is reported.

Limitations

  • The paper states that the described phenotypes are likely incomplete and that additional Dab2 physiological functions will continue to be uncovered.
  • The paper notes that redundancy with similar adaptors, especially Arh and Numb, may obscure physiological impacts, and that some speculated cellular functions may not be physiological due to low tissue expression.
  • The paper identifies unresolved mechanisms, including how Dab2-mediated LDL endocytosis in sinusoidal endothelial cells affects hepatocyte cholesterol synthesis and whether Dab2-positive pericytes are pre-adipocytes; evident from the text, the review also relies on cited literature including a “submitted” manuscript and does not use a systematic search or meta-analysis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fcell.2016.00129

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

71 of 174 cited sources checked · 33 supported · 3 flagged · accuracy not yet measured

Show all 86 claims

  • It may state two separate claims as one. 51
  • Probably not a substantial claim. 17
  • The quote only partly states this claim. 1
62 of 62
  • The paper relies on this without support.

    The Dab2 protein is essentially absent in the Sox2-Cre conditional knockout mutant mice.

    “despite that the Dab2 protein is essentially absent in the mutant mice”
1 of 1

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • PTB/PID domain placed at opposite ends of Dab2

    Minor

    This passage places the PTB/PID domain at the C-terminus, while the paper elsewhere places it at the N-terminus.

  • Kidney expression is attributed to the wrong figure

    Minor

    The kidney passage cites Figure 2 for tissue-expression profiling, but Figure 2 is about Ras/MAPK signaling. The tissue-expression profile is labeled Figure 3.

2 of 2

Citations

Cites

Flagged first, then by citations

Show all 98 references

4 of the 98 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

See all 45

Metadata

Authors
Tao, W., Moore, R., Smith, E. R., & Xu, X.-X.
Affiliations
University of Miami (US)
Corresponding author
Xu, Xiang-Xi
Venue
Frontiers in Cell and Developmental Biology
Published
2016-11-25
Volume
4
Pages
129-129
ISSN
2296-634X (ISSN-L)
OpenAlex
W2552899612
Cited by
43
References
98
Citations by year
2026: 1 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 7 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 3
FWCI
0.43
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Frontiers in Cell and Developmental Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Caveolin-1 and cellular processes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
Disabled-2, Dab2, clathrin adaptor proteins, endocytosis, PTB domain, NPXY motif, LDL receptor, LRP1, megalin, beta1 integrin, EGFR, fibroblast growth factor receptor, RAS/MAPK pathway, tumor suppressor, conditional knockout mice, developmental defects

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review